Skip to main content
BIR Issuancesby BetterGov.phBeta
Official source
Browse issuances
Revenue Memorandum Circular · RMC

RMC No. 110-2022

To publish the full text of the May 30, 2022 letter from the FDA OIC-Director General endorsing updates to the 'List of VAT-Exempt Medicines' under the CREATE Act (RA 11534).

Bureau of Internal RevenueIndependent research copy
Document type
RMC
Number
110
Year
2022
Text quality
Not specified

Document text

Reference copy · verify against the official source
RMC No. 110-2022 (issued July 21, 2022) publishes the full text of the FDA's May 30, 2022 letter endorsing updates to the 'List of VAT-Exempt Medicines' under the CREATE Act (RA 11534), which now includes certain medicines prescribed for cancer and COVID-19 treatment. Citing Q&A No. 1 of RMC No. 99-2021, the circular reiterates that the VAT exemption on the covered medicines and medical devices takes effect on the date the FDA publishes the updated list.